Articles From: Ultimate Selected to Present “Awesome New Technologies for HR” at the 2014 HR Technology Conference & Expo to Ultragenyx Announces Results From Phase 1/2 Study of KRN23 in X-linked Hypophosphatemia in Adults


Ultimate Software (Nasdaq: ULTI), a leading cloud provider of people management solutions, announced today that its new UltiPro Talent Acquisition solutions have been selected among the annual HR Technology ® Conference & Exposition’s “Awesome New Technologies for HR,” and will be featured in a general session at the conference on Thursday, October 9 at 1:30 p.m. at the Mandalay Bay Resort and Casino in Las Vegas.
Sign-up for Ultimate Selected to Present “Awesome New Technologies for HR” at the 2014 HR Technology Conference & Expo investment picks
Ultimate Software (Nasdaq: ULTI), a leading cloud provider of people management solutions, today announced its participation in a number of presentations at the 17th Annual HR Technology® Conference and Exposition, which will be held October 7-10 at Mandalay Bay Resort and Casino in Las Vegas.
Sign-up for Ultimate Software Announces Executive Presentations at 2014 HR Technology Conference investment picks
Ultimate Software (Nasdaq: ULTI), a leading cloud provider of people management solutions, announced today that it has delivered numerous enhancements to its HCM solution in the UltiPro Spring 2014 release, including a new compensation management product, additional talent analytics that help identify top talent, and the general availability of its new UltiPro Recruiting solution, first announced in October 2013.
Sign-up for Ultimate Software Enables Companies to Make More Effective Compensation Decisions with New Compensation Management Solution investment picks
Ultimate Software (Nasdaq:ULTI), a leading cloud provider of people management solutions, showed its new onboarding solution to attendees of the 2014 HR Technology® Conference, held October 7-10 at Mandalay Bay Resort and Casino in Las Vegas.
Sign-up for Ultimate Software Previews New Onboarding Solution at the 2014 HR Technology Conference investment picks
2014/7/21
Ultra Clean reports revenues at high end of guidance and exceeds EPS guidance for quarter on strong margin performance.
Sign-up for Ultra Clean Reports Second Quarter 2014 Financial Results investment picks
HAYWARD, Calif.
Sign-up for Ultra Clean to Announce Second Quarter 2014 Results investment picks
HAYWARD, Calif.
Sign-up for Ultra Clean to Announce Second Quarter 2014 Results investment picks
Ultra Petroleum Announces Executive Leadership Transition Canada NewsWire HOUSTON , July 15, 2014 /CNW/ -- Ultra Petroleum Corp.
Sign-up for Ultra Petroleum Announces Executive Leadership Transition investment picks
HOUSTON , July 15, 2014 /PRNewswire/ -- Ultra Petroleum Corp.
Sign-up for Ultra Petroleum Announces Executive Leadership Transition investment picks
HOUSTON , Aug.
Sign-up for Ultra Petroleum Announces Pinedale Acquisition investment picks
Ultra Petroleum Announces Pinedale Acquisition Canada NewsWire HOUSTON , Aug.
Sign-up for Ultra Petroleum Announces Pinedale Acquisition investment picks
HOUSTON , July 31, 2014 /PRNewswire/ -- Ultra Petroleum Corp.
Sign-up for Ultra Petroleum Announces Second Quarter And First Half 2014 Financial And Operating Results investment picks
HOUSTON , Sept.
Sign-up for Ultra Petroleum Corp. Announces $700 Million Offering of Senior Notes investment picks
Ultra Petroleum Corp.
Sign-up for Ultra Petroleum Corp. Announces $700 Million Offering of Senior Notes investment picks
Ultra Petroleum Corp.
Sign-up for Ultra Petroleum Corp. Announces Closing of Pinedale Acquisition investment picks
HOUSTON , Sept.
Sign-up for Ultra Petroleum Corp. Announces Closing of Pinedale Acquisition investment picks
Ultra Petroleum Corp.
Sign-up for Ultra Petroleum Corp. Announces Pricing of $850 Million Senior Note Offering investment picks
HOUSTON , July 31, 2014 /PRNewswire/ -- Ultra Petroleum Corp .
Sign-up for Ultra Petroleum Corp. To Webcast Second Quarter 2014 Results investment picks
2014/10/7
Ultra-wealthy “millennials,” those born between 1982-2000, are idealistic about the uses of their wealth, but say they are generally aligned with the values of their parents.
Sign-up for Ultra-Wealthy “Millennials” Are Idealistic, But Not Alienated; Challenge Stereotype of the “Idle Rich” investment picks
2014/9/19
NanoTech Entertainment (OTC Pink: NTEK ), a pioneer in bringing state-of-the-art television experiences to consumers, announced today that it UltraFlix will be demonstrated at 3 events in 10 major markets including Los Angeles, Dallas and Chicago.
Sign-up for UltraFlix Network Tours Ten Major Markets for Customer Demonstrations investment picks
NOVATO, Calif., July 14, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the closing of its public offering of 2,319,951 shares of common stock at a price to the public of $40.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 302,602 additional shares of common stock.
Sign-up for Ultragenyx Announces Closing of Public Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares investment picks
NOVATO, Calif., July 1, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, announced the first patient screened and enrolled in the Phase 2 study of the human monoclonal anti-FGF23 antibody KRN23 (UX023) in pediatric patients with X-linked hypophosphatemia (XLH). XLH is an inherited metabolic bone disease characterized by short stature, skeletal deformities, bone pain, fractures, and muscle weakness.
Sign-up for Ultragenyx Announces Initiation of a Phase 2 Study of KRN23 for Pediatric X-Linked Hypophosphatemia in the US and EU investment picks
NOVATO, Calif., July 9, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the pricing of its underwritten public offering of 2,017,349 shares of its common stock at a price to the public of $40.00 per share, before underwriting discounts.
Sign-up for Ultragenyx Announces Pricing of Public Offering of Common Stock investment picks
NOVATO, Calif., July 7, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that it has commenced an underwritten public offering of 2,017,349 shares of its common stock.
Sign-up for Ultragenyx Announces Proposed Public Offering of Common Stock investment picks
NOVATO, Calif., June 24, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the presentation of results from a multiple-dose study, conducted by Kyowa Hakko Kirin Pharma, Inc. (KKP), of the investigational anti-FGF23 monoclonal antibody KRN23 (UX023) in adult patients with X-linked hypophosphatemia (XLH). XLH is an inherited metabolic bone disease characterized by short stature, skeletal deformities, bone pain, fractures, and muscle weakness.
Sign-up for Ultragenyx Announces Results From Phase 1/2 Study of KRN23 in X-linked Hypophosphatemia in Adults investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Ultimate Selected to Present “Awesome New Technologies for HR” at the 2014 HR Technology Conference & Expo to Ultragenyx Announces Results From Phase 1/2 Study of KRN23 in X-linked Hypophosphatemia in Adults
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices